Welcome to our dedicated page for Smith & Nephew SEC filings (Ticker: SNN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Smith & Nephew plc (SNN) regulatory disclosures filed with the U.S. Securities and Exchange Commission, primarily through Form 6-K current reports for foreign private issuers. These filings give investors structured insight into the company’s capital structure, strategy, acquisitions and transactions by senior management.
Smith & Nephew uses Form 6-K to report a range of information, including announcements about its RISE strategy and related 2028 financial targets for revenue growth, trading profit, free cash flow and post-tax return on invested capital. Other 6-Ks detail portfolio rationalisation plans, guidance for upcoming financial years, and information on Capital Markets Day events where management presents strategic and product updates.
Filings also include voting rights and capital disclosures, setting out the total issued share capital, treasury shares and the number of voting rights that shareholders should use when assessing notification thresholds under applicable transparency rules. Separate TR-1 notifications, reproduced within 6-Ks, report major holdings changes by institutional investors such as BlackRock, Inc., including the percentage of voting rights attached to shares and through financial instruments.
Additional 6-K reports provide Market Abuse Regulation-compliant notifications of transactions by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them. These cover purchases of ordinary shares and American Depositary Shares, participation in dividend reinvestment and employee stock purchase plans, and vesting of restricted share awards, giving a view of insider dealing activity around SNN securities.
Investors can also find transaction-related disclosures, such as the acquisition of Integrity Orthopaedics and its Tendon Seam™ rotator cuff repair technology, including headline deal terms, strategic rationale within the Sports Medicine portfolio and comments from management. By combining real-time EDGAR updates with AI-powered summaries, this page helps users navigate Smith & Nephew’s 6-Ks, understand the implications of voting rights and insider transactions, and quickly grasp the strategic content of narrative announcements without reading every paragraph in full.
On 11 July 2025, Smith & Nephew plc filed a Form 6-K reporting insider share purchases carried out on 9 July 2025 under the Company’s Employee Stock Purchase Plan (ESPP). Chief Executive Officer Deepak Nath and four other persons discharging managerial responsibilities (PDMRs) bought American Depositary Shares (ADSs) on the New York Stock Exchange at a uniform price of US$29.77358 per ADS.
Individual purchases were: Nath and Paul Connolly, each 512.29508 ADSs; Craig Gaffin, 381.29219 ADSs; Scott Schaffner, 298.19045 ADSs; and Mizanu Kebede, 114.62247 ADSs. The combined volume equals roughly 1,819 ADSs, an aggregate consideration of about US$54,000. The disclosure was made in accordance with the UK Market Abuse Regulation; no additional financial metrics, guidance or strategic updates accompanied the filing.
While routine and modest in value, the insider buying may be interpreted as a limited vote of confidence by senior management. However, because the transactions occurred through a scheduled ESPP and represent a small fraction of daily trading volume, their market impact is expected to be minimal.